Lloyd Advisory Services, Llc. Regeneron Pharmaceuticals, Inc. Call Options Transaction History
Lloyd Advisory Services, Llc.
- $110 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
85.9MCall Options Held
1.06MPut Options Held
1.36M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.5 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.31 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.8 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.33 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...